
|Videos|February 18, 2021
Dr. Alexander Kutikov on the COVID-19 vaccine and patients with GU cancers
Author(s)Urology Times staff
“The biggest risk that our patients face is a severe COVID-19 episode,” says Kutikov.
Advertisement
Alexander Kutikov, MD, discusses his experience with the COVID-19 vaccine and patients with genitourinary cancer. Kutikov is chief, Division of Urology and Urologic Oncology, professor, Department of Surgical Oncology, and Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5






